Establishment of a Monoclonal Antibody Recognizing an Antigenic Site Common to Clostridium Botulinum Type B, C1, D, and E Toxins and Tetanus Toxin

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1988 Apr 1

PMID 2450068

Citations 16

Authors

K Tsuzuki

N Yokosawa

B Syuto

I OHISHI

N Fujii

K Kimura

K Oguma

Affiliations

Soon will be listed here.

Abstract

The partial amino acid sequence of the light-chain (Lc) component of Clostridium botulinum type C1 toxin was determined. The sequence was quite similar to those of the other types of botulinum and tetanus toxins. Nine monoclonal antibodies against botulinum type E toxin were established by immunizing BALB/c mice with type E toxoid or its Lc component. Six antibodies reacted with the heavy-chain component and three reacted with the Lc component of the toxin. One of the latter three antibodies reacted with botulinum type B, C1, and D toxins and tetanus toxin, as well as botulinum type E toxin. This antibody recognized the Lc components of these toxins, indicating that there exists one common antigenic determinant on the Lc regions of these toxins.

Citing Articles

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E.

Bever C, Scotcher M, Cheng L, Hnasko R, Stanker L Toxins (Basel). 2019; 11(7).

PMID: 31337022 PMC: 6669634. DOI: 10.3390/toxins11070407.

Detection of Neurotoxins Inhibited In Vivo by Botulinum Antitoxin B: Potential for Misleading Mouse Test Results in Food Controls.

Bano L, Tonon E, Drigo I, Pirazzini M, Guolo A, Farina G Toxins (Basel). 2018; 10(6).

PMID: 29921757 PMC: 6024680. DOI: 10.3390/toxins10060248.

Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Conway J, Sherwood L, Collazo M, Garza J, Hayhurst A PLoS One. 2010; 5(1):e8818.

PMID: 20098614 PMC: 2809108. DOI: 10.1371/journal.pone.0008818.

Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex.

Goldman E, Anderson G, Conway J, Sherwood L, Fech M, Vo B Anal Chem. 2008; 80(22):8583-91.

PMID: 18947189 PMC: 2829253. DOI: 10.1021/ac8014774.

Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Zarebski L, Vaughan K, Sidney J, Peters B, Grey H, Janda K Expert Rev Vaccines. 2008; 7(1):55-74.

PMID: 18251694 PMC: 3319117. DOI: 10.1586/14760584.7.1.55.

References

Yokosawa N, Tsuzuki K, Syuto B, Oguma K . Activation of Clostridium botulinum type E toxin purified by two different procedures. J Gen Microbiol. 1986; 132(7):1981-8. DOI: 10.1099/00221287-132-7-1981. View

OHISHI I, Iwasaki M, Sakaguchi G . Purification and characterization of two components of botulinum C2 toxin. Infect Immun. 1980; 30(3):668-73. PMC: 551367. DOI: 10.1128/iai.30.3.668-673.1980. View

Oguma K, Agui T, Syuto B, Kimura K, Iida H, Kubo S . Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Infect Immun. 1982; 38(1):14-20. PMC: 347689. DOI: 10.1128/iai.38.1.14-20.1982. View

OHISHI I . Oral toxicities of Clostridium botulinum type A and B toxins from different strains. Infect Immun. 1984; 43(2):487-90. PMC: 264322. DOI: 10.1128/iai.43.2.487-490.1984. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Syuto B, Kubo S . Isolation and molecular size of Clostridium botulinum type C toxin. Appl Environ Microbiol. 1977; 33(2):400-5. PMC: 170697. DOI: 10.1128/aem.33.2.400-405.1977. View

Syuto B, Kubo S . Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution. J Biol Chem. 1981; 256(8):3712-7. View

Nishi S, Yamazaki H . Monoclonal antibodies against AFP: application in immunoassay and affinity chromatography. Ann N Y Acad Sci. 1983; 417:452-8. DOI: 10.1111/j.1749-6632.1983.tb32887.x. View

Yamamoto K, OHISHI I, Sakaguchi G . Fluid accumulation in mouse ligated intestine inoculated with Clostridium perfringens enterotoxin. Appl Environ Microbiol. 1979; 37(2):181-6. PMC: 243184. DOI: 10.1128/aem.37.2.181-186.1979. View

10.

Eisel U, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U . Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 1986; 5(10):2495-502. PMC: 1167145. DOI: 10.1002/j.1460-2075.1986.tb04527.x. View

11.

Oishi I, Sakaguchi G . Purification of Clostridium botuliunum type F progenitor toxin. Appl Microbiol. 1974; 28(6):923-8. PMC: 186857. DOI: 10.1128/am.28.6.923-928.1974. View

12.

Kozaki S, Kamata Y, Nagai T, Ogasawara J, Sakaguchi G . The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Infect Immun. 1986; 52(3):786-91. PMC: 260927. DOI: 10.1128/iai.52.3.786-791.1986. View

13.

Oguma K, Syuto B, Iida H, Kubo S . Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun. 1980; 30(3):656-60. PMC: 551365. DOI: 10.1128/iai.30.3.656-660.1980. View

14.

Sathyamoorthy V, Dasgupta B . Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E. J Biol Chem. 1985; 260(19):10461-6. View

15.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

16.

Oguma K, Murayama S, Syuto B, Iida H, Kubo S . Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Infect Immun. 1984; 43(2):584-8. PMC: 264338. DOI: 10.1128/iai.43.2.584-588.1984. View

17.

Terajima J, Syuto B, Ochanda J, Kubo S . Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813. Infect Immun. 1985; 48(2):312-7. PMC: 261306. DOI: 10.1128/iai.48.2.312-317.1985. View